Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9480	Companies
185564	Keywords
117971	Articles
99400	Press releases

Home
Companies
Biophytis

BRIEF

published on 06/07/2024 at 07:44, 1 year 5 months ago

Assemblée générale mixte de Biophytis prévue le 24 juin 2024

Actionnaires Biophytis Paris Assemblée Générale Vote
BRIEF

published on 06/07/2024 at 07:44, 1 year 5 months ago

Biophytis Combined General Meeting scheduled for June 24, 2024

Shareholders Biophytis Paris General Assembly Vote
PRESS RELEASE

published on 06/07/2024 at 07:39, 1 year 5 months ago

Assemblée générale mixte du 24 juin 2024
Biophytis tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont invités à voter en amont par différents moyens. Infos sur le site web de la société

Actionnaires Biophytis Assemblée Générale Société De Biotechnologie Vote
PRESS RELEASE

published on 06/07/2024 at 07:39, 1 year 5 months ago

Combined General Meeting of June 24, 2024
Biophytis to hold Combined General Meeting (CGM) on June 24, 2024 at Sorbonne Université. Shareholders urged to vote in advance. Company specializes in age-related disease therapeutics

Shareholders Biophytis Therapeutics Combined General Meeting Age-related Diseases
BRIEF

published on 05/14/2024 at 07:05, 1 year 6 months ago

Biophytis lance une étude clinique phase 2 pour traiter l'obésité

Biophytis Étude Clinique Phase 2 BIO101 Obésité
BRIEF

published on 05/14/2024 at 07:05, 1 year 6 months ago

Biophytis Unveils Phase 2 OBA Clinical Study Design in Obesity

Biophytis Obesity Treatment Clinical Trial BIO101 OBA Clinical Study
PRESS RELEASE

published on 05/14/2024 at 07:00, 1 year 6 months ago

Biophytis announces the design of its phase 2 OBA clinical study in obesity
Biophytis announces the design of its phase 2 OBA clinical study in obesity with BIO101 (20-hydroxyecdysone), targeting muscle preservation in patients with obesity undergoing weight loss treatment with GLP-1 RAs

Biophytis BIO101 Muscle Preservation Obesity Phase 2 OBA Clinical Study
PRESS RELEASE

published on 05/14/2024 at 07:00, 1 year 6 months ago

Biophytis annonce le design de son étude clinique de phase 2 OBA dans l'obésité
Biophytis annonce le design de son ude clinique de phase 2 OBA dans l'ob sit e. La Soci t e se focalise sur le d fi m dical de l'ob sit e avec BIO101 (20-hydroxyecdysone) dans un traitement pour perdre du poids

Biophytis Traitement Étude Clinique BIO101 Obésité
REGULATED PRESS RELEASE

published on 05/14/2024 at 07:00, 1 year 6 months ago

Biophytis annonce le design de son étude clinique de phase 2 OBA dans l'obésité
Biophytis annonce le design de son étude clinique de phase 2 OBA dans l'obésité avec BIO101 (20-hydroxyecdysone), visant à évaluer l'efficacité et la sécurité chez des patients obèses sous GLP-1 RAs

Biophytis Étude Clinique BIO101 Obésité Phase 2 OBA
REGULATED PRESS RELEASE

published on 05/14/2024 at 07:00, 1 year 6 months ago

Biophytis announces the design of its phase 2 OBA clinical study in obesity
Biophytis announces the design of its phase 2 OBA clinical study in obesity with BIO101 (20-hydroxyecdysone), aiming to test efficacy and safety for muscle function in obese patients. Study to start mid-2024 with results expected in 2025

Biophytis BIO101 Obesity Phase 2 OBA Clinical Study Muscle Function

Accesswire

Published on 12/06/2025 at 02:00, 11 hours 22 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 12 hours 7 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 12 hours 57 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 13 hours 22 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 13 hours 52 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 15 hours 7 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 15 hours 10 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 18 hours 24 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 18 hours 56 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 19 hours 7 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 14 hours 22 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 14 hours 22 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 14 hours 22 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 14 hours 22 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 20 hours 4 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE